公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2006 | A pathway for TNFalpha -induced Bcl10 nuclear translocation: Bcl10 is upregulated by NFkappa B, phosphorylated by Akt1 and then complexes with Bcl3 to enter the nucleus. | Yeh, PY; Kuo, SH; Yeh, KH; Chuang, SE; Hsu, CH; Chang, WC; Lin, HI; Gao, M; Cheng, AL. | J Biol Chem | | | |
2004 | Phase II study of combination doxorubicin, interferon-alpha, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma. | Lu, YS; Hsu, C; Li, CC; Kuo, SH; Kun-Huei, Yeh; Yang, CH; Hsu, CH; Wu, CY; Cheng, AL. | Hepatogastroenterology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly paclitaxel and 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of recurrent or metastatic gastric cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Hsu, C; Kuo, SH; Li, SJ; Cheng, AL. | Oncology | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |
2005 | Phase II study of weekly vinorelbine and 24-hour infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancer. | Yeh, KH; Lu, YS; Hsu, CH; Lin, JF; Chao, HJ; Huang, TC; Chung, CY; Chang, CS; Cheng, AL. | Br J Cancer | | | |
2004 | Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr-dephosphorylation. | Yeh, PY; Kun-Huei, Yeh; Chuang, SE; Song, YC; Cheng, AL. | J Biol Chem 2004; | | | |